help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touraine, P.
Right arrow Articles by Kelly, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touraine, P.
Right arrow Articles by Kelly, P. A.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 2 667-674
Copyright © 1998 by The Endocrine Society


Original Studies

Increased Expression of Prolactin Receptor Gene Assessed by Quantitative Polymerase Chain Reaction in Human Breast Tumors Versus Normal Breast Tissues

Philippe Touraine, Jean-François Martini, Brigitte Zafrani, Jean-Claude Durand, Françoise Labaille, Catherine Malet, André Nicolas, Christine Trivin, Marie-Catherine Postel-Vinay, Frédérique Kuttenn and Paul A. Kelly

INSERM Unité 344, Faculté Medecine Necker (Ph.T., J-F.M., F.L., M-C.P.V., P.A.K.), 75730 Paris Cedex 15, France; Institut Curie (B.Z., A.N.), 75005 Paris, France; Clinique St. Jean de Dieu (J-C.D.), 75007 Paris, France; Département d’Endocrinologie, Hôpital Necker (C.M., F.K.), Paris, France; Laboratoire d’Explorations Hormonales, Hôpital Necker (C.T.), 75015 Paris, France

Address all correspondence and requests for reprints to: Philippe Touraine, INSERM Unité 344, Faculté Medecine Necker, 156 rue de Vaugirard, 75730 Paris Cedex 15, France.

The role of PRL in human breast tumorigenesis is not well understood. One of the limitations is the difficulty of accurately measuring PRL receptors (PRLR) in human tissues. We established a quantitative PCR method (Q-PCR) in T-47D human breast cancer cells and applied it to 29 patients, 25 of whom presented with either cancer or fibroadenoma. Four patients underwent a mammoplasty, and normal epithelial cells were cultured before Q-PCR. In T-47D cells, 31 x 106 messenger RNA molecules were detected per microgram of total RNA. In all patients, expression of the PRLR gene was detected, varying from 1500 to 1 x 106 molecules/µg of RNA in normal tissues and from 4500 to 34.7 x 106 molecules/µg of RNA in tumors. PRLR expression was always greater in tumor than in normal contiguous tissue and similar in cultured mammary epithelial cells and normal breast tissues. Estradiol and progesterone receptor-negative tumors expressed low levels of PRLR transcripts, similar to normal breast tissue from menopausal women. Immunocytochemical analysis of PRLR confirmed stronger staining in almost all tumor samples compared with normal tissues. A messenger RNA encoding locally produced human PRL was also identified by RT-PCR in every sample tested. Our results confirm PRLR gene expression in all tissues studied, and moreover, indicate that this expression is increased in human breast tumors vs. normal contiguous tissues.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society